| abstract |
The invention relates to compounds of Formula I: n n n n n n n n n n and pharmaceutically acceptable salts and prodrugs thereof, wherein R 1 , R 2 , and R 3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors. |